CDSCO monthly lab alert
CDSCO NSQ alert, July 2026: 239 drug batches flagged
By Blacklisted editorial team· Published 20 Aug 2026· Updated 20 Sep 2026· Source: CDSCO NSQ portal
In its July 2026 alert, the Central Drugs Standard Control Organisation listed 239 drug batches that failed quality tests, 40 at central laboratories and 199 at state drug-testing laboratories, from 206 manufacturers across 166 products. The most common failure was assay, and the most-represented manufacturing state was Himachal Pradesh. Products flagged include Ferrous Ascorbate & Folic Acid Tablets IP, Amoxycillin & Potassium Clavulanate Tablets IP, Telmisartan Tablets IP 40 mg.
239
Batches flagged
40 / 199
Central / state labs
Assay
Top reason
206
Manufacturers
Batches per month, last 12 alerts
Aug 2025Jul 2026 · 239
Full list of NSQ batches, July 2026
Download CSV| Product | Batch | Manufacturer | Reason declared NSQ | Tested by |
|---|---|---|---|---|
| ketoconazole, Chloridexidine Glueconate & Cetrinide Shampoo | L047D25Mfg 2025-04 · Exp 2027-03 | Disinfecto Chemical Industrial Pvt. Ltd. D-7Uttar Pradesh | Assay for chlorhexidine Gluconate onlyAssay | RDTL. Bellary KarnatakaState lab |
| ZEDCORIL EXPECTORANT | 0064Mfg 2026-04 · Exp 2029-03 | Lexine Technochem Pvt. LtdGujarat | Content of SalbutamolOther | FDL, VadodaraState lab |
| Vitamin A, Vitamin D3, Vitamin B1 and Niacinamide Tablets | CBT-0178Mfg 2025-09 · Exp 2027-02 | Crossasia Biotech Pvt. Ltd | The sample does not conform to Manufacturer's specification with respect to Assay of Vitamin A (Acetate) and Vitamin B1Assay | CDL, KolkataCDSCO lab |
| Triprolidine Hydrochloride & Codeine Phosphate Syrup, 100 ml | L-221226Mfg 2025-11 · Exp 2027-10 | BDC Pharmaceuticals 272 | Content of Triprolidine Hydrochloride & Codeine PhosphateOther | Lucknow LabState lab |
| Triamcinolone Acetonide Injection IP (40mg/ml) (1ml) | NPK0260Mfg 2024-12 · Exp 2027-11 | Nitin Life Sciences Ltd. Rampur RoadHimachal Pradesh | AssayAssay | Lucknow LabState lab |
| Tranexamic Acid Injection IP | TRI2502Mfg 2026-02 · Exp 2028-01 | Blitz Pharmaceuticals Pvt. Ltd | The sample does not conform to I.P. with respect to test for Particulate matter and is also not of standard quality for the reason stated under DescriptionDescription | CDL, KolkataCDSCO lab |
| Tolperisone & Paracetamol Tablets | TB26.084Mfg 2026-02 · Exp 2028-01 | Verax Life Sciences Pvt. LtdHimachal Pradesh | The sample does not conform to label claim with respect to content of Tolperisone HydrochlorideLabelling | Drugs Testing Laboratory, Madurai-19State lab |
| Terbinafine Hydrochloride Tablets IP 250mg | AT25110990AMfg 2025-11 · Exp 2027-10 | Accura Care Pharmaceuticals Pvt.LtdHimachal Pradesh | DissolutionDissolution | Drugs Testing Laboratory, Chennai-06State lab |
| Telmisartan Tablets IP 40mg | STS-114Mfg 2025-05 · Exp 2027-04 | Marc Lifesciences SikkimSikkim | DissolutionDissolution | Drugs Testing Laboratory, Chennai-06State lab |
| Telmisartan Tablets IP 40 mg | 493TTF004Mfg 2025-07 · Exp 2027-06 | Swiss Garnier Life SciencesHimachal Pradesh | The sample does not conform to IP standards. If fails the test Dissolution as per IPDissolution | DTL, TVPMState lab |
| Telmisartan Tablets IP 40 mg | 493TTF014Mfg 2025-08 · Exp 2027-07 | Swiss Garnier Life SciencesHimachal Pradesh | The sample does not conform to IP standards. It fails the test Dissolution as per IPDissolution | DTL, TVPMState lab |
| Telmisartan Tablets IP 40 mg | CT25624Mfg 2025-12 · Exp 2027-11 | Century Nova Drugs Pvt. Ltd | The Sample does not Comply for Description as the Tablets shows uneven Light Brown coloured Spots all over the Surface of the TabletsDescription | FDAL, Chhatrapati SambhajinagarState lab |
| Telmisartan Tablets IP 20 mg | HT250167Mfg 2025-08 · Exp 2027-07 | MEDICAMEN Biotech LtdUttarakhand | The sample received does not conform to the I.P. 2022 standard with respect to the test for Dissolution.Dissolution | CDTL, MumbaiCDSCO lab |
| Telmisartan & Hydrochlorothiazide Tablets IP | AMT-2460Mfg 2025-11 · Exp 2027-10 | Avalon Medicines Private LimitedHaryana | The sample received does not conform to i.p. 2022 specification with respect to the test for Dissolution of hydrochlorothiazide only.Dissolution | CDTL, HyderabadCDSCO lab |
| Telmisartan & Amlodipine Tablets I.P. | 2510095Mfg 2025-10 · Exp 2027-09 | Sai Sarvaa Biotech Pvt. Ltd | 01. ASSAY OF AMLODIPINE I.P. ?Less than prescribed limit.Assay | SFDTL UttarakhandState lab |
| Tapentadol Hydrochloride Tablets | T087J44Mfg 2026-01 · Exp 2027-12 | Biomax Biotechnics (P) LtdHaryana | The sample does not conforms to the claim with respect to Assay.Assay | DTL BikanerState lab |
| Spasmore (Acetaminophen, Tramadol HCl & Dicyclomine HCl Capsules). | SE026040Mfg 2026-04 · Exp 2028-03 | Danish Healthcare (P) Ltd | 01. ASSAY OF TRAMADOL HCL I.P. & DICYCLOMINE HCL I.P. ?Less than prescribed limit.Assay | SFDTL UttarakhandState lab |
| Soflgel Capsules Ferrous ascorbate Folic Acid &Zinc Soft Getatin Capsules | CD-251244BMfg 2025-01 · Exp 2027-05 | Capsoft Healthcare Pvt. Ltd. (An ISO & GMP Certified Company )Shed No. 6Himachal Pradesh | Description & Disintegration test "and does not conform to label claim with respect to " Assay for folic AcidAssay | RDTL. Bellary KarnatakaState lab |
| Sodium chloride injection IP 0.9% w/v | (N)25567Mfg 2025-11 · Exp 2027-10 | klokter Lifesciences private Ltd | Fail in AssayAssay | DTL, BaddiState lab |
| Sodium chloride injection IP 0.9% w/v | (N)25479Mfg 2025-09 · Exp 2027-08 | klokter Lifesciences private Ltd | Fail in AssayAssay | DTL, BaddiState lab |
| Sodium Chloride Injection IP 0.9%w/v | G2604H025Mfg 2026-05 · Exp 2028-04 | MKA Remedies Pvt. Ltd | The sample does not conforms to I.P. 2022 with respect to the test for Particulate contamination.Particulate matter | CDTL, MumbaiCDSCO lab |
| Sodium Bicarbonate Tablets I.P. 1000 mg | T-2509202Mfg 2025-09 · Exp 2027-08 | Rivpra Formulation Pvt. LtdUttarakhand | The sample does not conform to I.P (Addendum 2024) with respect to the Test of DisintegrationDisintegration | CDTL, IndoreCDSCO lab |
| Sodium Bicarbonat Tablets USP 500mg | 25087Mfg 2025-11 · Exp 2027-10 | Steadfast edishield Pvt. LtdUttarakhand | MisbrandingMisbranded | SDTL, RaipurState lab |
| Roller Bandage Non Sterilized | RC13Mfg 2025-12 · Exp 2028-11 | Mohan Pharma B-5/2Telangana | The Sample Does not conform to schedule F-II with respect to Description, Threads per dm (Warp) Length & Width.Description | DCL, TelanganaState lab |
| Ramipril Tablets IP 5mg | R25183701KMfg 2025-11 · Exp 2027-10 | Reltsen HealthcarePuducherry | Ramipril (64.20%)Other | Drugs Testing Laboratory, Madurai-19State lab |
| Racecadotril Capsules IP 100mg, | C042604Mfg 2026-04 · Exp 2028-03 | Swefn Pharmaceuticals Pvt. LtdGujarat | The sample does not conform to claim as per IP 2022 in respect to Assay of Racecadotril.Assay | RDTL, ChandigarhCDSCO lab |
| Rabeprazole Sodium Injection I.P. 20 mg/vial | MD24K17Mfg 2024-11 · Exp 2026-10 | Martin & Brown Bio-Sciences Pvt. LtdHimachal Pradesh | The sample does not conform to I.P. with respect to the Description, pH, Clarity of solution, Particulate matter and Assay of Rabeprazole SodiumAssay | CDL, KolkataCDSCO lab |
| Rabeprazole Sodium Gastro-Resistant Tablets I.P. | BLT-25798AMfg 2025-11 · Exp 2027-10 | Brit Lifescience V.P.O. MoginandHimachal Pradesh | MISBRANDED In the composition the label should be mentioned as Rabeprazoe sodium IP. But the label is mentioned as Rabeprazole Sodium equivalent to Rabeprazole. Hence it is misbranded drug as per section 17 of Drugs and Cosmetics Act 1940.Misbranded | DCL, TelanganaState lab |
| Rabeprazole Sodium (EC) & Domperidone (SR) Capsules | CG24-0548MMfg 2024-10 · Exp 2026-09 | Humankind Pharmaceuticals Lunia MohallaUttarakhand | Content of Rabeprazole SodiumOther | GORAKHPUR LAB, UPState lab |
| Rabepra zole Gastro Resistant Tablets IP 20 mg | T-2611 36Mfg 2025-11 · Exp 2027-10 | Merril Pharma Pvt. LtdUttarakhand | Dissolution TestDissolution | SDTL,Andhra Pradesh, VijayawadaState lab |
| R-Zara DSR Capsules | SC-08656Mfg 2026-01 · Exp 2027-12 | Samay Pharma India Pvt. Ltd. Plot No 34-35 Industrial Area. Trilokpur RoadHimachal Pradesh | The sample does not pass the following test Assay Rabeprazole Sodium per capsule is 0.0 mg against claim of 20mg and Domperidone per capsule is 0.0mg against claim of 30mg.Assay | Gov Analyst Analyst. Haryana ChandigarhState lab |
| Promethazine Injection I.P. 2ml | HLI992MMfg 2026-12 · Exp 2027-11 | Himalaya Meditek Pvt. Ltd.Plot No. 35&36Uttarakhand | The sample does not conform to I.P with respect to test for 'Particulate matter' and is also not of standard quality for the reason stated under Description.Description | CDL, KolkataCDSCO lab |
| Pregabalin IP 75mg, Nortripyline 10mg and Methylcobalamin IP 1500mcg, | ADT252729AMfg 2025-10 · Exp 2027-09 | Astonea Labs Pvt. LtdHaryana | The content of Methylcobalamin found to be 668.61 mcg per tablet (44.574%) against labelled claim of 1500 mcg per tablet.Labelling | Govt Analyst PunjabState lab |
| Pregabalin Capsules IP 300mg | DMC-260508AMfg 2026-05 · Exp 2028-04 | DIVINE MEDICARE | The Contents of Pregabali found to be 211.16mg/Capsule against the claim of 300.0mg/Capsule.Other | Govt Analyst PunjabState lab |
| Phenytoi Tablets IP 100mg | T-4710Mfg 2025-03 · Exp 2027-02 | Jackson Laboratories Pvt. LtdPunjab | The sample has been declared as NSQ quality with respect to Description.Description | RDTL. Bellary KarnatakaState lab |
| Pepsin & Fungal Diastase Syrup 200ml | MLS25934Mfg 2025-12 · Exp 2027-11 | MANCARE LABORATORIES Pvt LTD. Plot No 11 Pharmacity Selaqui DehradunUttarakhand | The content of fungal diastase in the sample is less(i.e.17.36% of the labelled amount) than the permissible limits.Labelling | FDAL, MumbaiState lab |
| Paracetamol, Phenylephrine HCL, Guaiphenesin, Cetirizine Hydrochloride & Ambroxol HCL Tablets | SBT-3351Mfg 2025-07 · Exp 2027-06 | Supercure Biotech Pvt. LtdHaryana | The sample is found to be Not of Standard Quality for the reason stated under Description.Description | CDL, KolkataCDSCO lab |
| Paracetamol Tablets IP 650mg. | AGT40557Mfg 2024-05 · Exp 2027-04 | Alventa Pharma LtdHimachal Pradesh | The sample does not conform to I.P. w.r.to the tests for DissolutionDissolution | CDL,KolkataState lab |
| Paracetamol Tablets IP 650mg | FT5427Mfg 2025-10 · Exp 2027-09 | Forgo PharmaceuticalsHimachal Pradesh | The sample does not conforms to the I.P. with respect to Dissolution Test.Dissolution | DTL BikanerState lab |
| Paracetamol Tablets IP 650mg | T60095Mfg 2026-03 · Exp 2028-02 | Zenith Drugs Ltd. 72/5 & 72/3Madhya Pradesh | The sample does not conform to I.P. w.r.to the tests for DissolutionDissolution | SDTL,GuwahatiState lab |
| Paracetamol Tablets IP 650 mg | UT-3765Mfg 2024-01 · Exp 2026-12 | Yacca Pharmaceutical Pvt. Ltd. 11 th KmUttarakhand | Dissolution testDissolution | SDT&RL, BhubaneswarState lab |
| Paracetamol Tablets IP 500mg | CHT-50351Mfg 2025-02 · Exp 2028-01 | Cotec Healthcare Pvt. LtdUttarakhand | The sample does not comply as per I.P. 2022 with respect to the test for Dissolution of Paracetamol.Dissolution | RDTL, GuwahatiCDSCO lab |
| Paracetamol Tablets IP 500 mg | PAK-825Mfg 2025-01 · Exp 2027-12 | Healer's Lab Unit IIHimachal Pradesh | The sample does not conform to the IP standards with respect to the test for DissolutionDissolution | DTL, ThrissurState lab |
| Paracetamol Paediatric Syrup IP 60 ml | PCS25194Mfg 2025-09 · Exp 2027-08 | Vivek Pharmachem(India) LtdRajasthan | The sample does not conform to IP standards. It fails the test Microbial Examination of Non- Sterile Product as per IP, as specified in the Laboratory protocol.Microbial limits | DTL, TVPMState lab |
| Paracet amol Tablets IP 650 mg | YT-250671EMfg 2025-10 · Exp 2027-09 | Yuventis Life SciencesHimachal Pradesh | Dissolution TestDissolution | SDTL,Andhra Pradesh, VijayawadaState lab |
| Paracet amol Tablets IP 500 mg | CTF2 5007Mfg 2025-09 · Exp 2028-08 | Curetech Formulations Pvt. LtdHimachal Pradesh | Dissolution TestDissolution | SDTL,Andhra Pradesh, VijayawadaState lab |
| Pantoprazole and Domperidone Tablets | T-241215Mfg 2024-12 · Exp 2026-11 | Medirose Drugs And Pharmaceuticals | The sample does not conform to claim with respect to above tests and The sample is not of standard quality for the reason stated under Description.Description | CDL, KolkataCDSCO lab |
| Pantoprazole and Domperidone Tablets | AN-06-25Mfg 2025-10 · Exp 2027-09 | Anchor Pharma Pvt. LtdDaman & Diu | TEST FOR DISINTEGRATION TIMEDisintegration | DTL, DelhiState lab |
| Pantoprazole Tablets IP | PEP5001Mfg 2025-02 · Exp 2027-01 | Finecure Pharmaceuticals Ltd. PF-5 & 6Gujarat | Dissolution testDissolution | SDT&RL, BhubaneswarState lab |
| Pantoprazole Tablets IP | AGW01AKAMfg 2025-09 · Exp 2027-08 | Pure & Cure Healthcare Pvt. LtdUttarakhand | The sample does not conform to IP standards. It fails the test Dissolution.Dissolution | DTL, KonniState lab |
| Pantoprazole Gastro-resistant Tablets IP 40 mg | SPK251470Mfg 2025-10 · Exp 2028-03 | Aristo Pharmaceuticals Pvt. Ltd. Plot Nos.: 2040-46Sikkim | Identification - Doesn't conforms to I.P.Identification | Lucknow LabState lab |
| Pantoprazole Gastro-resistant Tablets IP 40 mg | 25444650Mfg 2025-12 · Exp 2028-05 | Alkem Health ScienceSikkim | Identification - Doesn't conforms to I.P.Identification | Lucknow LabState lab |
| Pantoprazole Gastro-resistant Tablets IP | AT-1952AMfg 2025-06 · Exp 2027-05 | Azot Life SciencesHimachal Pradesh | Content of Pantoprazole (84.7%)Other | Drugs Testing Laboratory, Madurai-19State lab |
| Pantoprazole Gastro-resistant and Domperidone Prolonged- released Capsules IP | 25441645Mfg 2025-05 · Exp 2027-04 | Alkem Health ScienceSikkim | TESTS FOR ASSAY (CONTENT) OF PANTOPRAZOLE & UNIFORMITY OF WEIGHTAssay | DTL, DelhiState lab |
| Pantoprazole Gastro-resistant Tablets IP | GD25214Mfg 2025-12 · Exp 2027-11 | Skymap Pharmaceuticals Pvt. LtdUttarakhand | TEST FOR DISSOLUTIONDissolution | DTL, DelhiState lab |
| Pantoprazole Gastro-Resistant Tablets IP | R2516403JMfg 2025-10 · Exp 2027-09 | Reltsen Healthcare Spl Plot No. 9-11Puducherry | Sample Does not meets the Specifications wrt, Dissolution (All 6 Tablets dissolved in acid stage) as per IPDissolution | DCL, TelanganaState lab |
| Pantoprazole Gastro- Resistant & Domperidone Prologed Release Capsules I.P. | CG26-0049RMfg 2026-03 · Exp 2028-02 | Athens Life Sciences Mauza Rampur JattanHimachal Pradesh | 01. ASSAY OF PANTOPRAZOLE SODIUM I.P. & DOMPERIDONE I.P. ? Less than prescribed limit.Assay | SFDTL UttarakhandState lab |
| Pantopr azole Gastro Resistant Tablets IP20 mg | CIT-8736Mfg 2025-12 · Exp 2027-11 | Conscaff IndiaHimachal Pradesh | Dissolution TestDissolution | SDTL,Andhra Pradesh, VijayawadaState lab |
| Pacimol MF 250 Suspension | INCO14030RMfg 2024-09 · Exp 2027-08 | Ipca Laboratory Ltd. Sejavta | Suspension does not dispose uniformaly on shakingOther | DTL Jabalpur (M.P.)State lab |
| Pacimol MF 250 Suspension | INCO14035RMfg 2024-10 · Exp 2027-09 | Ipca Laboratory Ltd. Sejavta | Suspension does not dispose uniformaly on shakingOther | DTL Jabalpur (M.P.)State lab |
| PHENYLEPHRINE HYDROCHLORIDE AND CHLORPHENIRAMINE MALEATE SYRUP IP | XL260053Mfg 2026-01 · Exp 2027-12 | Xcell LabsHimachal Pradesh | pHpH | Govt Analyst PunjabState lab |
| Oxytocin Injection IP 5IU/ml, | I-7881Mfg 2025-11 · Exp 2027-10 | Jackson Laboratories Pvt. Ltd. 22-24Punjab | The sample failed in Identification test of OxytocinIdentification | DTL, DelhiState lab |
| Oxytocin Injection IP 5IU/ml | I-7881Mfg 2025-11 · Exp 2027-10 | Jackson Laboratories Pvt.LtdPunjab | The sample does not conform to claim as per IP 2022 in respect to the Test of Identification by HPLC and Particulate MatterIdentification | RDTL, ChandigarhCDSCO lab |
| Orlistat Capsules USP 120 mg | TPC25015Mfg 2025-09 · Exp 2027-08 | Taj Pharma India LtdGujarat | 01.IDENTIFICATION TEST OF ORLISTAT U.S.P. ? Found to be negative. 02. ASSAY OF ORLISTAT U.S.P.: NIL.Assay | SFDTL UttarakhandState lab |
| Oral Rehydration salts IP(ORS) | CHPLO- 002Mfg 2026-02 · Exp 2028-01 | Cureza Healthcare Pvt. Ltd. 63/1Madhya Pradesh | The sample does not conform to claim as per IP in respect to test for DescriptionDescription | SDTL, JharkhandState lab |
| Oral Rehydration Salts IP | 4063Mfg 2026-05 · Exp 2028-04 | Super Formulations Pvt Ltd | Net WeightWeight | Govt Analyst PunjabState lab |
| Oral Rehydration Salts IP | 4057Mfg 2026-05 · Exp 2028-04 | Super Formulations Pvt Ltd | Net WeightWeight | Govt Analyst PunjabState lab |
| Oral Rehydration Salts I.P | ODSC-1010Mfg 2025-11 · Exp 2027-10 | Nestor Pharmaceuticals LtdHaryana | Sample does not conform to IP standards. It fails the test Assay as per IP and hence declared as Not of Standard QualityAssay | RDTL ErnakulamState lab |
| Ondansetron Tablets IP 4 mg | TB251158Mfg 2026-01 · Exp 2027-12 | Agron Remedies Pvt. Ltd | The sample received does not conform to i.p. 2022, ip addendum 2024 specification with respect to the test for related substances (total impurities) only.Related substances | CDTL, HyderabadCDSCO lab |
| Ondansetron Tablets IP 4 mg | TG252335Mfg 2025-11 · Exp 2027-10 | Symbiosis Pharmaceuticals Pvt. Ltd. - (Plant-I) Symbiosis HouseHimachal Pradesh | Assay & DissolutionAssay | Lucknow LabState lab |
| Ondansetron Orally Disntagrating Tablets IP | SPT252281Mfg 2025-10 · Exp 2027-09 | Salus PharmaceuticalHimachal Pradesh | The sample has been declared as NSQ as it does not conform to IP standard with respect to Test for DisintegrationDisintegration | RDTL. Bellary KarnatakaState lab |
| Ondansetron Orally Disintegration Tablets IP | ST-34645Mfg 2024-10 · Exp 2026-09 | Samay Pharma India Pvt. Ltd Plot No.- 34-35Himachal Pradesh | Disintegration TestDisintegration | Lucknow LabState lab |
| Omerprazole Capsules I.P 20 mg. | OPZDC4059Mfg 2024-11 · Exp 2026-10 | Laborate Pharmaceutical India Ltd. 111 | Test for Dissolution for Omeprazole both at Acid and Buffer StageDissolution | RDTL, Bellary KarnatakaState lab |
| Omeprazole Gastro-resistant Capsules IP 20 mg | GC108503Mfg 2025-03 · Exp 2027-02 | Bengal Chemicals & Pharmaceuticals LtdHimachal Pradesh | The sample does not conform to IP standards with respect to the test for Dissolution.Dissolution | DTL, ThrissurState lab |
| Omeprazole & Domperidone Capsules | AC25/211Mfg 2026-01 · Exp 2027-12 | Accuwell Medics Private Ltd. Suvery No.-414Gujarat | Content of Omeprazole & DomperidoneOther | Lucknow LabState lab |
| Ofloxacin Metronidazole and Simethicone Suspension | OXG2501Mfg 2025-09 · Exp 2027-08 | Apple Formulations Pvt. LtdUttarakhand | Content of Metronidazole (45.68%)Other | Drugs Testing Laboratory, Madurai-19State lab |
| Obelow-60 (Orlistat Capsules USP 60 mg | TPC26003Mfg 2026-01 · Exp 2027-12 | Taj Pharma India LtdGujarat | 01. IDENTIFICATION TEST OF ORLISTAT U.S.P. ? Found to be negative. 02. ASSAY OF ORLISTAT U.S.P.: NIL.Assay | SFDTL UttarakhandState lab |
| ONEM Injection | 70425008EMfg 2025-11 · Exp 2027-10 | Onxy Biotec Ltd. Unit-II Vill. TeliwalaHimachal Pradesh | pHpH | ChandigarhState lab |
| Nimesulide & Paracetamol Tablets | Not MentionedMfg ? · Exp ? | Euphoria India PharmaceuticalsHimachal Pradesh | MISBRANDED DRUGS.Misbranded | SFDTL UttarakhandState lab |
| Nifedipine Sustained Release Tablets IP 10mg | ANY25001Mfg 2025-12 · Exp 2028-11 | J.B. Chemicals & Pharmaceuticals LtdGujarat | The sample does not conforms to the claim with respect to Dissolution (Acid Stage).Dissolution | DTL JaipurState lab |
| Nicoz-5 Nicorandil Tablets IP 5 mg | NBT-251045Mfg 2025-10 · Exp 2027-09 | A.N.D Healthcare LtdPunjab | Sample does not conform to IP Standards. If fails the test 'Dissolution' and 'Assay'Assay | RDTL ErnakulamState lab |
| Milk of Magnesia, Liquid Paraffin & Sodium Picosulfate Suspension | UF2834807BMfg 2024-10 · Exp 2026-09 | Ultra Durgs Formulations Pvt. Ltd. Plot no. 338/278Himachal Pradesh | Description onlyDescription | RDTL. Bellary KarnatakaState lab |
| Midazolam injection I.P-1mg-5ml | MZ-2606Mfg 2026-01 · Exp 2027-12 | Vindas Chemical Industries (P) Ltd. Plot No.65 | pH (4.1) and Assay (87.2%)Assay | King Institute of Preventive Medicine & Research, Guindy, Chennai-32State lab |
| Metronidazole and Povidone Iodine Ointment | XOJM25015Mfg 2025-07 · Exp 2027-06 | Helios Pharmaceuticals (Div. of P.K.T.P. Pvt LtdHimachal Pradesh | The sample does not conform to Label claim with respect to the content of Availabe Iodine in Povidone Iodine(79.59%)Labelling | Drugs Testing Laboratory, Madurai-19State lab |
| Metronidazole Tablets IP 400 mg | T4500Mfg 2024-11 · Exp 2027-04 | Titanes Pharma | The sample does not conforms to the IP with respect to Dissolution.Dissolution | DTL JaipurState lab |
| Metronidazole Tablets IP 200 mg | MZ241001Mfg 2024-10 · Exp 2026-09 | Cipco Pharmaceuticals 35-36/1Madhya Pradesh | The Dissolution test Does Not Complies as per IP Specification, hence it is of Not of Standard Quality.Dissolution | DCL, TelanganaState lab |
| Metronidazole Tablets IP 200 mg | ME025002Mfg 2025-12 · Exp 2028-11 | Danish Healthcare (P) Ltd. 76/27-29 | Uniformity of WeightUniformity of weight/content | Lucknow LabState lab |
| Metronidazole Infusion B.P. 0.5% w/v | L04A032607Mfg 2026-03 · Exp 2029-02 | Althea Pharma Pvt. LtdDaman & Diu | The sample does not comply as per B.P. 2025 with respect to the test for Sterility.Sterility | RDTL, GuwahatiCDSCO lab |
| Methylprednisolone Tablets I.P. | NHD24554AMfg 2024-11 · Exp 2026-10 | Nest Healthcare Pvt. LtdGujarat | The sample does not conform to IP with respect to the test for DissolutionDissolution | CDTL, IndoreCDSCO lab |
| Methylcobalamin Alpha Lipoic Acid Pyridoxine HCL Folic Acid &Vitamin D3 Tablets | LC25F031CMfg 2025-06 · Exp 2026-11 | Life care Neuro Products Ltd. 70/1Himachal Pradesh | Disintegration testDisintegration | RDTL, Bellary KarnatakaState lab |
| Metformin Hydrochloride Prolonged-Released and Glimepiride Tablets IP | 60002727Mfg 2026-03 · Exp 2028-02 | USV Private LimitedGujarat | The sample does not conform to claim as per Manufacture's Specification with respect to the test for Dissolution of Metformin Hydrochloride.Dissolution | CDTL, IndoreCDSCO lab |
| Mefenamic Acid & Paracetamol Tablets | T-252174Mfg 2025-03 · Exp 2027-02 | Merril Pharma Pvt.LtdUttarakhand | The sample does not conform to Schedule V of the Drugs Rule 1945 with respect to the test disintegration.Disintegration | DTL, ThrissurState lab |
| METHOTREXATE TABLETS IP 7.5 MG | L09-2501Mfg 2025-02 · Exp 2027-01 | Macmillon Pharmaceuticals Pvt LtdPunjab | DescriptionDescription | Govt Analyst PunjabState lab |
| METHOTREXATE TABLETS IP 7.5 MG | L09-2402Mfg 2024-12 · Exp 2026-11 | Macmillon Pharmaceuticals Pvt LtdPunjab | DescriptionDescription | Govt Analyst PunjabState lab |
| Levofloxacin Tablets IP 500 mg | JC00116Mfg 2026-01 · Exp 2027-12 | Lupin Ltd. EPIPJammu & Kashmir | Identification - Doesn't conforms to I.P.Identification | Lucknow LabState lab |
| Levodropropizine & Chlorpheniramine Maleate Syrup | FL5024Mfg 2025-06 · Exp 2027-05 | Forgo PharmaceuticalsHimachal Pradesh | The sample does not conform to Manufacturer's specification with respect to test for'pH and Assay of Chlorpheniramine Maleate.Assay | CDL, KolkataCDSCO lab |
| Levocetirizine Dihydrochloride Tablets I.P. | B13225006Mfg 2025-11 · Exp 2027-10 | TORQUE PHARMACEUTICALS Pvt. LTD | The sample does not conform to the I.P. with respect to Dissolution of Levocetirizine Dihydrochloride.Dissolution | DTL JodhpurState lab |
| Levocetirizine & Montelukast Sodium Dispersible tablets | ABC04ABAMfg 2025-12 · Exp 2027-11 | Pure & Cure Healthcare Pvt. LtdUttarakhand | The sample does not conform to Label claim with respect to content of Montelukast in Montelukast sodium)Labelling | Drugs Testing Laboratory, Madurai-19State lab |
| Lactic Acid Bacillus Capsules | DY0225060Mfg 2025-11 · Exp 2027-10 | Uni MedicolabsUttarakhand | The sample does not conform to Manufacturer's specification with respect to test for Microbial Limit Test with regard to Total Yeast and Mold countMicrobial limits | CDL, KolkataCDSCO lab |
| KUFFTUSS-Q Tablets | IGT-0511Mfg 2024-12 · Exp 2027-11 | IG Pharma Ltd. 12.4 KM Meerut Road Roorkee Dist. Haridwar (U.K.)Uttarakhand | Mottled appeareanceOther | DTL Jabalpur (M.P.)State lab |
| KT Kids Cleansing Shampoo Soothes the scalp 200 ML | KTK0012Mfg 2026-04 · Exp 2028-04 | CCIGMAA LIFESTYLE Pvt LTD. 12 ACO-OP 2 nd FloorMaharashtra | The Sample Does Not Comply With Is 17117:2019 (Reaffirmed 2024) For Hair Shampoo For Babies Specification Req(Jirements For Micribial Count. The Sample Is Misbranded for the Manner of Labelling As Given Rule 34(10) (e) and rule 35 of cosmetics rule 2020.Misbranded | FDAL, MumbaiState lab |
| Itraconazole, Capsules IP | CG25-0392AMfg 2025-11 · Exp 2027-10 | Athens Life Sciences Mauza-Rampur Jatten Nahan RoadHimachal Pradesh | AssayAssay | Lucknow LabState lab |
| Itraconazole 100mg IP | MC004Mfg 2025-07 · Exp 2027-06 | MK Healthcare | 1. The content of Itraconazole found to be 63.54 mg per capsule (63.54%) against labelled claim of 100 mg per capsule. 2. The composition on the label is not as per I.P monographLabelling | Govt Analyst PunjabState lab |
| Iron, Folic Acid, Cyanocobalamin & Zinc Sulphate Syrup | BV616Mfg 2025-10 · Exp 2027-03 | Biva Healthcare | The sample does not conform to claim as per Schedule V of Drugs and Cosmetics Rules 1945 with respect to Assay of Cyanocobalamin.Assay | CDL, KolkataCDSCO lab |
| Iron n& Folic Acid Tablets I? | QT1572Mfg 2025-03 · Exp 2027-02 | Quest Laboratories Ltd. Plot No. 45Madhya Pradesh | The sample does not conform to claim as per IP in respect to test for DescriptionDescription | SDTL, JharkhandState lab |
| Ibuprofen Tablets I.P. 400 mg | IBPT-1003Mfg 2024-07 · Exp 2027-06 | Wings Biotech LLPHimachal Pradesh | The sample does not comply as per I.P. 2022 with respect to the test for Dissolution of Ibuprofen.Dissolution | RDTL, GuwahatiCDSCO lab |
| Ibuprofen Tablets IP 200 mg | INR25036Mfg 2025-11 · Exp 2027-10 | Danish Healthcare (P) Ltd. 76/27-29 | DissolutionDissolution | Lucknow LabState lab |
| Handloom Rolled Bandages | 024Mfg 2026-01 · Exp 2027-12 | Kota Saree Avam Hath kargha Vastra Utpadak Kray-Vikray Sahakari Samiti Ltd | The sample does not conform to claim as per Schedule F-(II) with respect to test for FluorescenceOther | CDL, KolkataCDSCO lab |
| Hajmola Regular | BM1250Mfg 2026-03 · Exp 2028-02 | Dabur India LtdHimachal Pradesh | Total 120 Tablets received for analysis,out of 120 Tablets, 13 Tablets are found in broken condition and some powder is found in container when observed in normal day light with unaided eyes.Other | FDAL, Chhatrapati SambhajinagarState lab |
| Glipizide Tablets IP | SPA252473Mfg 2025-11 · Exp 2027-10 | Skymap Pharmaceuticals Pvt. LtdUttarakhand | Does not conform to IP Standards with respect to Dissolution TestDissolution | Food & Drugs Laboratory Bambolim, GoaState lab |
| Glimepiride, Ploglitazonehci & Metformin HCI (SR) Tablets | DPT-016Mfg 2025-04 · Exp 2027-03 | Demexico Pharmaceuticals Pvt. LtdUttarakhand | The sample has been declared as NSQ as it does not conform to label claim with respect to Assay for Metformin Hydrochloride and PioglitazoneAssay | RDTL. Bellary KarnatakaState lab |
| Glimepiride Tablets IP 4mg | T2512152Mfg 2025-12 · Exp 2027-11 | Rivpra Formulation Pvt. Ltd; Plot No. 8Uttarakhand | Does not conform to IP Standards with respect to Dissolution TestDissolution | Food & Drugs Laboratory Bambolim, GoaState lab |
| Glimepiride Tablets IP 2mg | CHPLT1027Mfg 2025-12 · Exp 2027-11 | Cureza Healthcare Pvt. LtdMadhya Pradesh | The Sample does not Comply with IP Requirements for the Dissolution Test.Dissolution | FDAL, Chhatrapati SambhajinagarState lab |
| Glimepiride Tablets IP 1mg | GTA-2501Mfg 2025-01 · Exp 2027-01 | Apple Formulations Pvt. LtdUttarakhand | The sample does not conform to standard quality in respect of the test for ?Description? performed.Description | SDTL, Tripura, AgartalaState lab |
| Glimepiride Tablets IP | 5GAC030Mfg 2025-12 · Exp 2028-11 | Sanofi India LtdGoa | DissolutionDissolution | Lucknow LabState lab |
| Gliclazide Extended release Tablets 60 mg | T511617Mfg 2025-11 · Exp 2027-10 | ION Healthcare Pvt. Ltd.Baddi- Barotiwala Road Baddi Distt. Solan (H.P) 173205Himachal Pradesh | test for Dissolution for Gliclazide at 4th hour and 12th hour as per Manufacturer's methodDissolution | RDTL. Bellary KarnatakaState lab |
| Folic Acid Tablets IP | F0L1T5010Mfg 2025-10 · Exp 2027-09 | Acme Life Tech-LLPHimachal Pradesh | The sample does not comply as per I.P. 2022 with respect to the test for Dissolution of Folic Acid.Dissolution | RDTL, GuwahatiCDSCO lab |
| Folic Acid Tablets IP | SPT-41378Mfg 2025-11 · Exp 2027-10 | Shervotec PharmaceuticalsHimachal Pradesh | The sample does not comply as per I.P. 2022 with respect to the test for Dissolution of Folic acid.Dissolution | RDTL, GuwahatiCDSCO lab |
| Flexon Suspension | DPK241894Mfg 2024-10 · Exp 2027-09 | Aristo Pharmaceuticals Pvt. Ltd. Survey No. 371Daman & Diu | Suspension does not dispose uniformaly on shakingOther | DTL Jabalpur (M.P.)State lab |
| Ferrous Ascorbate, Folic Acid and Cyanocobalamin Suspension | 18260226AMfg 2026-01 · Exp 2028-12 | Macleods Pharmaceuticals Ltd. - Khasra No. 21Sikkim | Identity test negative for Folic Acid & content of Elemental IronOther | Lucknow LabState lab |
| Ferrous Ascorbate & Folic Acid Tablets IP | LTA-45315AMfg 2024-10 · Exp 2026-09 | Life Vision HealthcareHimachal Pradesh | The sample does not conform to I.P. w.r.to the tests for AssayAssay | SDTL,GuwahatiState lab |
| Ferrous Ascorbate & Folic Acid Tablets IP | FAM-677Mfg 2025-08 · Exp 2027-01 | Healer's Lab Unit II Plot NO. 33Himachal Pradesh | NSQOther | DTL BhopalState lab |
| Ferrous Ascorbate & Folic Acid Tablets IP | FAM-656Mfg 2025-08 · Exp 2027-01 | Healer's Lab Unit II Plot NO. 33Himachal Pradesh | NSQOther | DTL BhopalState lab |
| Ferrous Ascorbate & Folic Acid Tablets IP | FAM-629Mfg 2025-05 · Exp 2026-10 | Healer's Lab Unit II Plot NO. 33Himachal Pradesh | NSQOther | DTL BhopalState lab |
| Ferrous Ascorbate & Folic Acid Tablets IP | FAM-649Mfg 2025-05 · Exp 2026-10 | Healer's Lab Unit II Plot NO. 33Himachal Pradesh | NSQOther | DTL BhopalState lab |
| Ferrous Ascorbate & Folic Acid Tablets IP | FAM-628Mfg 2025-05 · Exp 2026-10 | Healer's Lab Unit II Plot NO. 33Himachal Pradesh | NSQOther | DTL BhopalState lab |
| Ferrous Assorbate, Folic Acid and Cyanocobalamin Suspension | 18260226AMfg 2026-01 · Exp 2028-12 | Macleods Pharmaceuticals Ltd. Khasra No. 21Sikkim | 01. ASSAY OF FOLIC ACID I.P. ?Less than prescribed limit.Assay | SFDTL UttarakhandState lab |
| Ferric Carboxymaltose Injection 50 mg/ml | RC26003Mfg 2026-01 · Exp 2027-12 | Maan Pharmaceuticals LtdGujarat | The sample does not conform to Manufacturer's specification with respect to test for Particulate matter and Bacterial endotoxins.Particulate matter | CDL, KolkataCDSCO lab |
| FORMALDEHYDE SOLUTION B.P. | F-25Mfg 2025-12 · Exp 2027-11 | VINAYAK MANUTRADE (P) LTDRajasthan | The sample does not conforms to the BP with respect to Description.Description | DTL JaipurState lab |
| Dynaflex Plus | VGT240120Mfg 2024-06 · Exp 2027-05 | Vapi Care Pharma Pvt. Ltd. Plot No. 225/3 | NSQOther | DTL BhopalState lab |
| Drotaverine Hydrochloride & Diclofenac Potassium Tablets | KFCR6023Mfg 2026-03 · Exp 2028-02 | Cris Pharma (India) Ltd. E-11Uttarakhand | Identification - Doesn't conforms to I.P.Identification | Lucknow LabState lab |
| Dr. Wash Intimate Hygiene | IW-0225Mfg 2025-02 · Exp 2028-01 | Magic of Herbs Magic of Herbs Haryana-133001Haryana | Idetity test Negative for Lactic AcidOther | VARANASI,UPState lab |
| Disposable Syringe for Single Use Only (STERILIFE) 2ml | 052502GX01Mfg 2025-05 · Exp 2028-04 | STERISAFE HEALTH SOLUTIONS | The sample does not comply as per IP 2022 with respect to the test for Sterility.Sterility | RDTL GuwahatiState lab |
| Dinoprostone Gel | H-084Mfg 2025-02 · Exp 2027-01 | COTEC HEALTHCARE Pvt. LTDUttarakhand | The sample does not conforms to the claim with respect to Average fill, Uniformity of weight and Assay.Assay | DTL JaipurState lab |
| Dinoprost Tromethamine Injection | VPT409Mfg 2025-09 · Exp 2027-08 | Vetsun PharmaceuticalsUttarakhand | pHpH | Govt Analyst PunjabState lab |
| Diclofenac Sodium and Paracetamol Tablets IP | I501103Mfg 2025-02 · Exp 2027-01 | Zydus Healthcare LtdSikkim | Description & DissolutionDissolution | Lucknow LabState lab |
| Diclofenac Sodium Tablets IP 50mg | SP250935Mfg 2025-09 · Exp 2027-08 | Sharun Pharmaceuticals Pvt.LtdPuducherry | DissolutionDissolution | Drugs Testing Laboratory, Chennai-06State lab |
| Diclofenac Sodium Tablets IP 50mg | SP250934Mfg 2025-09 · Exp 2027-08 | Sharun Pharmaceuticals Pvt.LtdPuducherry | DissolutionDissolution | Drugs Testing Laboratory, Chennai-06State lab |
| Diclofenac Sodium Tablets IP 50 mg | DG 5033Mfg 2025-03 · Exp 2027-02 | Kerala State Drugs Pharmaceuticals LtdKerala | The sample does not conform to IP standards with respect to the test Dissolution and also shows Category B defect of tablets (Capping).Dissolution | DTL, ThrissurState lab |
| Diclofenac Sodium Injection I.P. | ZYCD15018Mfg 2025-10 · Exp 2027-09 | Laborate Pharmaceuticals India Ltd. 111Himachal Pradesh | Content of Diclofenac SodiumOther | KANPUR LAB, UPState lab |
| Diclofenac Sodium Gastro -Resistant Tablets IP | T-25056Mfg 2025-09 · Exp 2027-08 | Geson Pharma Pvt. Ltd Industrial AreaUttar Pradesh | Disintegration TestDisintegration | MEERUT LABState lab |
| Diclofenac Sodium & Paracetamol Tablets | AHT-2502262Mfg 2026-02 · Exp 2028-01 | Aru Health Care Pvt. Ltd. - K-12 | Disintegration TestDisintegration | Lucknow LabState lab |
| Diclofenac Gastro-Resistant Tablets IP | 250264AMfg 2025-05 · Exp 2028-04 | Bal Pharma LimitedUttarakhand | The sample does not conform to I.P 2022 with respect to test for Related substancesRelated substances | CDTL, MumbaiCDSCO lab |
| Diclofenac Diethylamine, Virgin Linseed oil, Menthol & Methyl Salicylate Gel | JDB766Mfg 2025-02 · Exp 2027-01 | Curetech SlincareHimachal Pradesh | The sample does not conform to label claim with respect to the content of Diclofenac Diethylamine,and Methyl SalicylateLabelling | Drugs Testing Laboratory, Chennai-06State lab |
| Diabetis-All Powder | A-1Mfg 2025-07 · Exp 2030-07 | Dr. Puri Proprietory Product | The Sample gives TLC and HPLC [dentification Test for the Presence of Pioglitazone Hydrochloride. lFound Content of Pioglitazone Hydrochloride: 0.32mg/gm. The Sample is declared as Spurious Vide Section 33-EEA(d) of Drugs And Cosmetics Act 1940 and Rules thereunder.Spurious | FDAL, Chhatrapati SambhajinagarState lab |
| Dextromethorphan HBr, Phenylephrine HCl & Chlorpheniramine Maleate Syrup). | ABSL25-0183AMfg 2025-10 · Exp 2027-09 | Alexin BiosciencesHimachal Pradesh | MISBRANDED DRUGS.Misbranded | SFDTL UttarakhandState lab |
| Dexamethasone Tablets IP 0.5 mg | KJKBH25134Mfg 2025-11 · Exp 2028-10 | Cadila Pharmaceuticals Ltd. Industrial Growth Center | DissolutionDissolution | Lucknow LabState lab |
| Deomax-LB (Amoxycillin. Cloxaeillin & Lactic Acid Closacillin & Lacne Acd Bacillus Capsules | JPC-3100Mfg 2024-10 · Exp 2026-09 | JMH Pharma. Plot No. Is Handwar Road 82. Handwar RoadUttarakhand | The sample does not pass the Assay of Anhy drous Amoxycillin & Cloxacillin per capsule is 10.86 mg & 67.73 mg against the claimed 250 mg.Assay | Gov Analyst Analyst. Haryana ChandigarhState lab |
| Cypermethion 10% High Cis | 9023Mfg 2025-08 · Exp 2027-07 | Mac Royal Biotech Baddi RoadHimachal Pradesh | Assay for Cypermethrin highcisAssay | RDTL. Bellary KarnatakaState lab |
| Culse The Beauty soap papaya Fruit Mix | CT06Mfg 2025-01 · Exp 2027-05 | Goodbuy Beauty Prohtets Door no. 13/515 A | Test for Matter Insolubic in AlcoholOther | RDTL. Bellary KarnatakaState lab |
| Compound Sodium Lactate Injection IP | EE26A003Mfg 2026-01 · Exp 2027-12 | Hindustan PolyfabHimachal Pradesh | The sample does not conform to I.P. with respect to test for Sterility.Sterility | CDL, KolkataCDSCO lab |
| Compound Sodium Lactate Injection I.P. | EE26A006Mfg 2026-01 · Exp 2027-12 | Hindustan PolyfabHimachal Pradesh | The sample does not conform to I.P. with respect to test for Sterility.Sterility | CDL, KolkataCDSCO lab |
| Colecalciferol Drops | 26-XJFD-098Mfg 2026-04 · Exp 2027-09 | Stedman Pharmceuticals Pvt.Ltd | The sample does not conform to claim with respect to the test for Related substances.Related substances | CDL, KolkataCDSCO lab |
| Clopidogrel & Aspirin Tablets IP | P0825176TMfg 2025-08 · Exp 2027-07 | Pharmaroots HealthcareHimachal Pradesh | Dissolution, Free Salicylic Acid, Content of Clopidogrel (38.20%) and Aspirin (21.8%)Dissolution | Drugs Testing Laboratory, Chennai-06State lab |
| Clopidogrel & Aspirin Tablets | TSF-C2763Mfg 2024-10 · Exp 2026-09 | Spen Formulations Pvt. Ltd | DescriptionDescription | Drugs Testing Laboratory, Chennai-06State lab |
| Clopidogrel & Aspirin Tablets | GT31923CMfg 2026-02 · Exp 2028-01 | J.M.LaboratoriesHimachal Pradesh | Free salicylic Acid (12.01%) and Content of Aspirin (77.13%)Other | Drugs Testing Laboratory, Chennai-06State lab |
| Clobetasol Propionate, Neomycin, Miconazole Nitrate & Chlorhexidine Cream | DLPS5111Mfg 2025-11 · Exp 2027-10 | Leeford Healthcare LtdHimachal Pradesh | Content of Chlorhexidine (51.5%)Other | Drugs Testing Laboratory, Chennai-06State lab |
| Ciprofloxacin Hydrochloride Tablets IP 250mg | T50540Mfg 2025-12 · Exp 2027-11 | Zenith Drugs LtdMadhya Pradesh | The sample does not conform to I.P. w.r.to the tests for DissolutionDissolution | SDTL,GuwahatiState lab |
| Cinnarizine Tablets IP | MV115027Mfg 2025-12 · Exp 2028-11 | Geno Pharmaceuticals Pvt. LtdGoa | Identification - Doesn't conforms to I.P.Identification | Lucknow LabState lab |
| Chlorhexidine Mouthwash IP | WOR25041GMfg 2025-12 · Exp 2028-11 | Windlas Biotech Limited (Plant-2)Uttarakhand | The sample does not conform to claim as per I.P. 2022 with respect of test for Assay of Chlorhexidine Gluconate.Assay | RDTL, GuwahatiCDSCO lab |
| Cetin Plus Suspension 60ml | GL027412Mfg 2024-12 · Exp 2026-11 | Asian Pharma Khasra No. 105-106 village Katha Baddi 173205 HPHimachal Pradesh | NSQOther | DTL BhopalState lab |
| Celltus-B (Ambroxol Hydrochloride, Terbutaline Sulphate, Guaiphenesin & Menthol Syrup) | CLAM-2525Mfg 2025-12 · Exp 2027-11 | Comex Pharma | 01. ASSAY OF TERBUTALINE SULPHATE I.P. ?Less than prescribed limit.Assay | SFDTL UttarakhandState lab |
| Cefuroxime Axetil & Potassium Clavulanate Tablets I.P. | CXCA25014EMfg 2025-08 · Exp 2027-01 | J.M LaboratoriesHimachal Pradesh | The sample does not conform to I.P. with respect to the tests of Dissolution and Assay of Cefuroxime and Clavulanic Acid.Assay | CDL, KolkataCDSCO lab |
| Cefpodoxime Proxetil Oral Suspension IP | LBL2501002Mfg 2026-01 · Exp 2027-12 | Life Gem Medi Healthcare (India) I.P. - 46 Raipur Sahkari Audhyogic KshetraUttarakhand | AssayAssay | Lucknow LabState lab |
| Cefpodoxime Proxetil IP 200 mg Tablets | SRTC-2403Mfg 2025-08 · Exp 2027-07 | Velnex Medicare India Pvt. Ltd | Identification - Doesn't conforms to I.P.Identification | Lucknow LabState lab |
| Cefpodoxime Proxetil & Clavulanic Acid Tablets | BT-0564Mfg 2025-09 · Exp 2027-02 | Addll Biotech Pvt. Ltd. Vill. KaundiHimachal Pradesh | Identity test negative for Cefpodoxime Proxetil & Clavulanic AcidOther | Lucknow LabState lab |
| Cefpodoxime Dispersible Tablets Nexopod -100DT | BL-033E25Mfg 2025-05 · Exp 2027-04 | Austin Pharmaceuticals Ltd.(A GMP CERTIFIED COMPANY) E-40Punjab | The sample fails in the test, DescriptionDescription | DTL,DALGATE SRINAGAR KASHMIR( J AND K)State lab |
| Cefpodoxime & Ofloxacin Tablets | C9AKX031Mfg 2024-12 · Exp 2026-11 | Relax Pharmaceuticals Pvt. Ltd. - (Unit-II) 49-A-BHimachal Pradesh | Identity test negative for Cefpodoxime Proxetil & OfloxacinOther | Lucknow LabState lab |
| Cefixime, Ofloxacine & Lactic Acid Bacillus Tablets | ST-25190Mfg 2026-01 · Exp 2027-12 | Candimed Life SciencesUttarakhand | Identity test negative for Cefixime & OfloxacinOther | Lucknow LabState lab |
| Cefixime, Azithromycin and Lactic Acid Bacillus Tablets | TB25115Mfg 2025-03 · Exp 2027-02 | Forgo Pharmaceuticals (P) Ltd. Plot No. 92 Industrial AreaHaryana | Content of anhydrous AzithromycinOther | GORAKHPUR LAB, UPState lab |
| Cefixime, Azithromycin & Lactic Acid Bacillus Tablets | ST-25193Mfg 2025-01 · Exp 2027-12 | Candimed Life SciencesUttarakhand | Identity test negative for Cefixime & AzithromycinOther | Lucknow LabState lab |
| Cefixime, Azithromycin & Lactic Acid Bacillus Tablets | PL-26089Mfg 2025-09 · Exp 2027-08 | Velnex Medicare India Pvt. Ltd | Identity test negative for Cefixime & AzithromycinOther | Lucknow LabState lab |
| Cefixime with Lactic Acid Bacillus Dispersible Tablets | CT/25/792Mfg 2026-01 · Exp 2027-12 | Ciphem PharmaGujarat | The sample does not conform to the claim with respect to Assay of Cefixime Trihydrate Eq. to Anhydrous Cefixime.Assay | DTL JaipurState lab |
| Cefixime Tablets IP | 25460922Mfg 2025-05 · Exp 2027-04 | Alkem Health Sciences A Unit of Alkem Laboratories Ltd. Unit-3Sikkim | Identification - Doesn't conforms to I.P.Identification | Lucknow LabState lab |
| Cefixime Dispersible Tablets IP 200mg | 25D-BT150Mfg 2025-07 · Exp 2027-06 | Orison Pharma InternationalHimachal Pradesh | The Sample does not Comply for Description as the Tablets shows Light Brown coloured Spots all over the Surface of the Tablets.Description | FDAL, Chhatrapati SambhajinagarState lab |
| Cefixime Dispersible Tablets IP | DB240368Mfg 2024-12 · Exp 2026-11 | Daxin Pharmaceuticals Pvt. Ltd. Plot No. 121-122 EPIPHimachal Pradesh | The sample does not conform to I.P. w.r.to the tests for AssayAssay | SDTL,GuwahatiState lab |
| Cefixime Dispersible Tablets I.P. | CCT-24035Mfg 2024-07 · Exp 2026-06 | Catrax Healthcare Pvt. LtdHimachal Pradesh | 01. ASSAY OF CEFIXIME TRIHYDRATE I.P. ?Less than prescribed limit.Assay | SFDTL UttarakhandState lab |
| Cefixime & Ofloxacin Dispersible Tablets | T4646Mfg 2024-11 · Exp 2027-04 | Titanes Pharma | The sample does not conform to the claim with respect to Assay, Uniformity of dispersion and Disintegration.Assay | DTL JaipurState lab |
| Cefixime & Lactic Acid Bacillus Tablets | DF-8021Mfg 2026-03 · Exp 2028-02 | Velnex Medicare India Pvt. Ltd | Identity test negative for CefiximeOther | Lucknow LabState lab |
| Cefixime & Azithromycin Tablets | MWDC-5421GMfg 2026-01 · Exp 2027-12 | Geenac PharmaUttarakhand | Identity test negative for Cefixime & AzithromycinOther | Lucknow LabState lab |
| Carvedilol Tablets IP 6.25mg | P1225138TAMfg 2025-12 · Exp 2027-11 | Pharma Roots HealthcareHimachal Pradesh | DissolutionDissolution | Drug testing laboratory, Chennai-6State lab |
| Calcium citarate malate, Vitamain k2 -7 , Vitamin D3, methylcobalamin Zinc and Magnesium Tablets | 25KHT-0857Mfg 2025-08 · Exp 2027-07 | Kaalimga Healthcare 1st FloorHimachal Pradesh | test for Disintegration and label claim woth respect to the Identification and Assay for Vitamin D3Assay | RDTL. Bellary KarnatakaState lab |
| Calcium and Vitamin D3 Tablets IP 500mg/250 IU | PJCT-021Mfg 2025-02 · Exp 2027-01 | Laborate Pharmaceuticals India Ltd . # 31Himachal Pradesh | Identification of Vitamin D3 - Doesn't conforms to I.P.Identification | Lucknow LabState lab |
| Calcium and Vitamin D3 Tablets IP 500mg/250 I.U | PJCT-016Mfg 2025-02 · Exp 2027-01 | Laborate Pharmaceuticals India Ltd. 31 Rajban Road nariwalaHimachal Pradesh | Assay for Vitamin D3Assay | RDTL. Bellary KarnatakaState lab |
| Calcium and Vitamin D3 Tablets IP | CH26T203Mfg 2026-05 · Exp 2027-10 | Cureza Healthcare Pvt LtdMadhya Pradesh | Dissolution :-(Calcium) Does not complies with IP limit as 3 out of 6 tablets are less than Q-25% Also some tablets can't even dissolve completely within the prescribed time limit.Dissolution | Govt Analyst PunjabState lab |
| Bupropion Hydrochloride Prolonged Release Tablets IP | LGT-260293Mfg 2026-02 · Exp 2028-01 | Live Well HealthcareHimachal Pradesh | The sample does not conform to claim as per IP 2022 in respect to the Test of Identification by HPLC, Identification by IR and Assay of Bupropion Hydrochloride.Assay | RDTL, ChandigarhCDSCO lab |
| Buprenorphine Injection IP. 2ml | BUP324040Mfg 2024-12 · Exp 2026-07 | Indus Pharma Pvt. LtdRajasthan | The sample does not conform to I.P. with respect to tests of Particulate matter and Assay of Buprenorphine.Assay | CDL, KolkataCDSCO lab |
| Buprenorphine 2 mg and Naloxone 0.5 mg Sublingual Tablets IP | 25CT0314Mfg 2025-03 · Exp 2027-02 | Consern Pharna LtdPunjab | The sample is of not of standard quality for the reason stated under DescriptionDescription | RDTL,GuwahatiState lab |
| Buprenorphine 2 mg and Naloxone 0.5 mg Sublingual Tablets I.P. | 25CT0314Mfg 2025-03 · Exp 2027-02 | Consern Pharma LimitedPunjab | The sample is not of standard quality for the reason stated under Description of the tablets.Description | RDTL, GuwahatiCDSCO lab |
| Bithoquin Bolus | V260301Mfg 2026-03 · Exp 2027-06 | Apple Biotech Healthcare Pvt. Ltd. Vill. Deep NagarPunjab | Disintegration TestDisintegration | AGRA,State lab |
| Bisacodyl Tablets IP 5mg | 8676Mfg 2026-03 · Exp 2029-02 | Healthy Life Pharma Pvt. LtdMaharashtra | The sample does not conform to I.P. w.r.to the tests for AssayAssay | SDTL,GuwahatiState lab |
| Betamethasone, Clindamycin & Nicotinamide Cream | 1391Mfg 2026-02 · Exp 2028-01 | Lucrose Pharma Pvt. Ltd. Flat No. 197Uttar Pradesh | Content of Betamethasone & ClindamycinOther | GORAKHPUR LAB, UPState lab |
| Betamethasone valerate & Salicylic Acid Ointment | BE533Mfg 2025-06 · Exp 2027-05 | Bestcare Formulation PvtPuducherry | Content (Nil)Other | Drug testing laboratory, Chennai-6State lab |
| Betamethasone Valerate Ointment IP | RF695Mfg 2025-06 · Exp 2027-05 | Curetech SkincareHimachal Pradesh | Content of Betamethasone (73.7%)Other | Drugs Testing Laboratory, Chennai-06State lab |
| Betamethasone Sodium Phosphate Injection I.P. | HL11006MMfg 2025-12 · Exp 2027-11 | Himalaya Meditek Pvt. LtdUttarakhand | The sample does not conforms to the IP with respect to Description, Particulate Matter and Assay.Assay | DTL JaipurState lab |
| BETAMETHASONE VALERATE AND NEOMYCIN SKIN CREAM | YW6KMfg 2026-02 · Exp 2027-07 | GlaxoSmithKline Pharmaceuticals LtdMaharashtra | The Sample does not conform to claim with respect to the Assay of Neomycin Sulphate.Assay | DTL, DelhiState lab |
| Atorvastatin and Clopidogrel Tablets | PGT25-3110AMfg 2025-11 · Exp 2027-10 | Plena RemediesHimachal Pradesh | Does not conform to required standards with respect to the test AssayAssay | Food & Drugs Laboratory Bambolim, GoaState lab |
| Atorvastatin Tablets IP 10mg | AV26072Mfg 2026-04 · Exp 2027-09 | Eurokem Laboratories Pvt Ltd | DissolutionDissolution | Drugs Testing Laboratory, Chennai-06State lab |
| Amoxyclllin CapsulesIP 250mg | MBC-111Mfg 2024-10 · Exp 2026-09 | Mayasha Lifesciences H.B. 86 Village Bhatian Nalagarh Dist. Solan HP 174101Himachal Pradesh | The sample fails to comply in respect of contains of the drug which is less than the calimOther | DTL BhopalState lab |
| Amoxycillin, Potassium Clavulanate & Lactic Acid Bacillus Tablets | BR-1227Mfg 2026-03 · Exp 2027-08 | Velnex Medicare India Pvt. Ltd | Identification - Doesn't conforms to I.P.Identification | Lucknow LabState lab |
| Amoxycillin and Potassium Clavulanate Tablets IP (500 mg+125mg | CVTC-815Mfg 2025-09 · Exp 2027-08 | Nestor Pharmaceuticals Ltd. 11Haryana | Content of Clavulanic AcidOther | GORAKHPUR LAB, UPState lab |
| Amoxycillin and Potassium Clavulanate Tablets IP | CBZ19ADAMfg 2025-12 · Exp 2027-11 | Malik Lifesciences Pvt. Ltd. - (A Subsidiary of Akumes Drugs & Pharmaceuticals Ltd.) Plot NO. 16Uttarakhand | Dissolution of AmoxycillinDissolution | Lucknow LabState lab |
| Amoxycillin Oral Suspension IP | AMS2532Mfg 2025-06 · Exp 2026-11 | Modern LaboratoriesMadhya Pradesh | Content of Amoxycillin.Other | FDL, VadodaraState lab |
| Amoxycillin Dispersible Tablets IP | UOT25-522Mfg 2025-09 · Exp 2027-08 | Unisharp Organics Pvt. Ltd. Alamgir | AssayAssay | Lucknow LabState lab |
| Amoxycillin Capsules IP 500mg | BC12250010Mfg 2025-05 · Exp 2027-04 | Alencure Biotech Pvt.Ltd. Village: NagalHimachal Pradesh | Content of Amoxycillin (82.7%)Other | Drugs Testing Laboratory, Chennai-06State lab |
| Amoxycillin &Potassium Clavulanate Tablets | Not MentionedMfg ? · Exp ? | Astam Healthcare Pvt. LtdHimachal Pradesh | MISBRANDED DRUGS.Misbranded | SFDTL UttarakhandState lab |
| Amoxycillin & Potassium Clavulanate, Lactic Acid Bacillus Tablets | MWDC-5421GMfg 2026-01 · Exp 2027-12 | Sabi Pharmaceuticals Pvt. Ltd - . Shivnath Gogoi PathAssam | Identity test negative for Amoxycillin & Clavulanic AcidOther | Lucknow LabState lab |
| Amoxycillin & Potassium Clavulanate Tablets IP | KT25030Mfg 2025-02 · Exp 2027-01 | Orbit Lifescience Pvt. Ltd | The sample does not conform to I.P. w.r.to the tests for Dissolution and Assay of Clavulanic AcidAssay | CDL,KolkataState lab |
| Amoxycillin & Potassium Clavulanate Tablets IP | VT251527Mfg 2025-09 · Exp 2027-02 | VADSP PharmaceuticalsHimachal Pradesh | The sample does not conform to I.P. w.r.to the tests for Dissolution and Assay of Clavulanic AcidAssay | CDL,KolkataState lab |
| Amoxycillin & Potassium Clavulanate Tablets IP | 826D074Mfg 2026-03 · Exp 2027-08 | Medreich LtdKarnataka | Identification - Doesn't conforms to I.P.Identification | Lucknow LabState lab |
| Amoxycillin & Potassium Clavulanate Tablets IP | MFL0122Mfg 2025-03 · Exp 2027-02 | Medicef PharmaHimachal Pradesh | Identification - Doesn't conforms to I.P.Identification | Lucknow LabState lab |
| Amoxycillin & Potassium Clavulanate Tablets IP | TB250343CMfg 2025-06 · Exp 2027-02 | Polestar Power Industries - (PHARMA DIVISION) Vill. DamuwalaHimachal Pradesh | Identification - Doesn't conforms to I.P.Identification | Lucknow LabState lab |
| Amoxycillin & Potassium Clavulanate Tablets I.P. | HPT25002Mfg 2025-06 · Exp 2026-11 | Hariom PharmaceuticalsHimachal Pradesh | The sample does not conform to claim as per I.P. 2022 with respect to the test for Assay and Dissolution of Amoxycillin and Clavulanic Acid.Assay | RDTL, GuwahatiCDSCO lab |
| Amoxycillin & Cloxacillin Capsules | ZABG2611Mfg 2026-05 · Exp 2027-10 | Malik Lifesciences Pvt. LtdUttarakhand | The sample does not conform to Manufacture's Specification with respect to the test for Assay of Amoxycillin Trihydrate eq. to Amoxycillin and Cloxacillin Sodium equivalent to Cloxacillin and Dissolution Cloxacillin Sodium equivalent to CloxacillinAssay | CDTL, IndoreCDSCO lab |
| Amoxicillin and Potassium Clavulanate Tablets IP | 26440256Mfg 2026-01 · Exp 2027-06 | Alkem Health Sciences A Unit of Alkem Laboratories Ltd. Unit-2Sikkim | Identification - Doesn't conforms to I.P.Identification | Lucknow LabState lab |
| Amino Acids (10%w/v) Injection with Electrolytes, Dextrose Injection IP (15%w/v) and Intravenous Fat Emulsion with Medium & Long Chain Triglycerides (20% w/v) in a Triple Chamber Bag | 5D250116Mfg 2025-04 · Exp 2027-03 | Acculife Healthcare Pvt. LtdGujarat | The sample does not conform to claim with respect to Assay of L-Cysteine Hydrochloride Monohydrate, Sterility and Bacterial Endotoxin test of Infusion set.Assay | CDL, KolkataCDSCO lab |
| Amikacin Sulphate Injection IP 250mg/2ml | PVI25042Mfg 2025-12 · Exp 2027-11 | Plica Vaccines Pvt. Ltd | The sample does not conform to I.P. with respect to test for Particulate matter and is also not of standard quality for the reason stated under Description.Description | CDL, KolkataCDSCO lab |
| Ambroxol Hydrochloride, Terbutaline Sulphate, Guiaphenesin & Menthol Syrup | FMX-030/26Mfg 2026-03 · Exp 2028-02 | Finemax Formulation Private LtdTamil Nadu | The sample does not conform to label claim with respect to the content of Ambroxol Hydrochloride and Terbutaline Sulphate.Labelling | Drugs Testing Laboratory, Chennai-06State lab |
| Ambroxol Hydrochloride, Terbutaline Sulphate, Guaiphenesin & Menthol Syrup | BGL250945Mfg 2025-09 · Exp 2027-08 | Bestcare Formulation PvtPuducherry | Content of Ambroxol Hydrochloride(75.7%) and Terbutaline Sulphate (85.6%)Other | Drugs Testing Laboratory, Chennai-06State lab |
| Alprazolam Tablets IP 0.5mg | TA25315Mfg 2025-03 · Exp 2028-02 | SAINTLIFE PHARMACEUTICALS LTDUttarakhand | The sample does not conform to the IP with respect to Dissolution.Dissolution | DTL JaipurState lab |
| Alprazolam Tablets IP 0.50 mg | AT25417Mfg 2025-10 · Exp 2028-09 | Aarpik Pharmaceuticals Pvt. Ltd. C1/306/5Kerala | Identification - Doesn't conforms to I.P.Identification | Lucknow LabState lab |
| Alfacalcidol with Calcium Carbonate Capsules | CA-3160034Mfg 2026-01 · Exp 2027-06 | Centurion Remedies Pvt. LtdGujarat | The sample does not conform to Manufacturer Specification with respect to the tests for Uniformity of weight and Assay of Alfacalcidol.Assay | CDL, KolkataCDSCO lab |
| Albendazole Tablets IP 400mg | MT251013Mfg 2025-10 · Exp 2027-09 | Mancare Laboratories Pvt.LtdUttarakhand | DissolutionDissolution | SDTL, RaipurState lab |
| Albendazole Tablets IP 400 mg | SP250907Mfg 2025-09 · Exp 2027-08 | Sharun Pharmaceuticals Pvt.LtdPuducherry | Uniformity of WeightUniformity of weight/content | Drugs Testing Laboratory, Madurai-19State lab |
| Albendazole Tablets IP 400 mg | SAO-210Mfg 2025-12 · Exp 2028-11 | SikkimSikkim | DissolutionDissolution | Lucknow LabState lab |
| Aceclofenac, Paracetamol and Serratiopeptidase Tablets | F9AHY065Mfg 2025-10 · Exp 2027-09 | Pharma Force Lab 53-55Himachal Pradesh | Identity test negative for Aceclofenac and Content of ParacetamolOther | Lucknow LabState lab |
| Aceclofenac, Paracetamol & Serratiopeptidase Tablets | TG25-1919BMfg 2025-10 · Exp 2027-09 | Menrik Biomerge Pvt. Ltd. 5Delhi | Content of AceclofenacOther | GORAKHPUR LAB, UPState lab |
| Aceclofenac and Parcetamol IP) | T251733CMfg 2025-09 · Exp 2027-08 | Bajaj Formulations Khasra No. 161Uttarakhand | 01. ASSAY OF ACECLOFENAC I.P. ?Less than prescribed limit.Assay | SFDTL UttarakhandState lab |
| Aceclofenac Sustained Release and Enteric Coated Rabeprazole Sodium Capsules | C50200BMfg 2025-12 · Exp 2027-11 | Samson Laboratories Pvt. LtdHimachal Pradesh | The sample received does not conform to manufacturers specification with respect to the test for Assay of rabeprazole sodium content only.Assay | CDTL, HyderabadCDSCO lab |
| Aceclofenac 100 mg, Serratiopeptidase 15 mg & Paracetamol 325 mg Tablets | FND0825055AKMfg 2025-12 · Exp 2028-05 | Ipca Laboratories Ltd. Unit-IISikkim | Identity test negative for Aceclofenac and ParacetamolOther | Lucknow LabState lab |
| Aceclofenac & Paracetamol Tablets IP | MT250239Mfg 2025-06 · Exp 2028-05 | Oxford PharmaUttarakhand | Content of Aceclofenac (82.94%)Other | Drugs Testing Laboratory, Madurai-19State lab |
| Aceclofenac & Paracetamol Tablets IP | T-2504296Mfg 2025-04 · Exp 2028-03 | Gopal LifesciencesHimachal Pradesh | DissolutionDissolution | Lucknow LabState lab |
| Aceclofenac & Paracetamol Tablets | T2601006/AMfg 2026-01 · Exp 2028-12 | Empree Medicament India Pvt. Ltd | Does not conform to IP Standards with respect to Dissolution TestDissolution | Food & Drugs Laboratory Bambolim, GoaState lab |
| Aceclofenac & Paracetamol Tablets | BLPT-053Mfg 2026-04 · Exp 2028-03 | Bonn Stering Bio Science LLP. Plot No. 64 & 65 Electronic parkPuducherry | Content of Aceclofenac (81.98%) and Paracetamol (81.62%)Other | Drugs Testing Laboratory, Madurai-19State lab |
| Acctaminophen Oral suspension I.P. 125 mg | HL76Mfg 2025-03 · Exp 2027-02 | Azine Healthcare Pvt.ltd Plot no. 401Kerala | Description and Assay for ParacetamolAssay | RDTL. Bellary KarnatakaState lab |
| AZITHROMYCIN ORAL SUSPENSION IP 200 MG/5ML | 41410Mfg 2024-10 · Exp 2026-09 | ZENITH DRUGS Ltd. 72/5 & 72/3Madhya Pradesh | 1. The content of azithromycin in the sample is less(i.e. 65.76% of the labelled amount than the i.p. Limits. 2.Tthe sample is infested with fungus growth. all the observations are done in normal daylight conditions with unaided eyes.4xl5 ml intact brown coloured plastic bottles received for analysis. When opens for analysis, it is observed that in all these 4X15 ML bottles particles are stick around the neck of the bottle. During analysis when the content from these 4x15 ml bottles after shaking transferred individually in clean dry sterilised glass beaker, contains yellow coloured suspension. Yellow coloured suspension which mixes uniformly after shaking.Labelling | FDAL, MumbaiState lab |
| ASPIRIN TABLET IP 75MG | 240968Mfg 2024-09 · Exp 2027-08 | MODI ANTIBIOTICS Plot No-28 G.I.D.C. Estate Odhav Ahmedabad 382415Gujarat | l]five (5) intact strips often (10) tablets each were received for analysis. When the strips were opened for analysis and observed in normal daylight conditions with unaided eyes it was observed that, each pocket of the strip contains off whte,circular tablets with shiny needle shape crystals all over the surface. The tablets are very brittle in nature. 2. The content of aspirin in the sample is less (i.e.0.32% oof the labelled amount) than the i.p.limits.Labelling | FDAL, MumbaiState lab |
| ASPIRIN TABLET IP 75MG | 250168Mfg 2025-01 · Exp 2027-12 | MODI ANTIBIOTICS Plot No-28 G.I.D.C. Estate Odhav Ahmedabad 382415Gujarat | 1. five (5) intact strips of ten (10) tablets each were received for analysis. When the strips were opened for analysis and observed in normal daylight conditions with unaided eyes it was observed that, each pocket of the strip contains off whte,circular tablets with shiny needle shape crystals all over the surface. The tablets are very brittle in nature. 2 The co tent of aspirin in the sample is less (i.e.0.32% oof the labelled amount) than the i.p.limits.Labelling | FDAL, MumbaiState lab |
| ASPIRIN GASTRO- RESISTANT TABLETS I.P. 75 MG | CBT-0254Mfg 2025-10 · Exp 2027-09 | Crossasia Biotech Pvt. Ltd. Survery No. 488 A.B. Road Girwai industrial Area Beldarpura Gwalior 474002 (M.P) | Description test for Salicylic Acid Assay for Aspirin and test for DissolutionAssay | RDTL. Bellary KarnatakaState lab |
Suspected spurious batches in this alert
| Product | Batch | Labelled manufacturer | Reported by | Firm's reply |
|---|---|---|---|---|
| Buprenorphine Injection I.P. 2ml | LM1888 | Under Investigation | CDL, Kolkata | The actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug. |
Check your medicine. Enter the batch number printed on the strip, bottle or carton to see whether it appears in this or any earlier alert. Check a batch number
Official sources and primary records
- Regulator
- Regulator
Changelog
- 20 Sep 2026: table generated from the CDSCO NSQ portal export (239 rows). Revised CDSCO lists are diffed on each monthly rebuild.